Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Jul;17(7):899-901.
doi: 10.1513/AnnalsATS.201911-840RL.

Potential Contribution of Pulmonary Thromboembolic Disease in Pulmonary Hypertension in Sickle Cell Disease

Mehdi Nouraie  1 , Xu Zhang  2 , Andrew Srisuwananukorn  2 , Roberto F Machado  3 , Victor R Gordeuk  2 , Mark T Gladwin  1 , Santosh Saraf  2
Affiliations
Randomized Controlled Trial

Potential Contribution of Pulmonary Thromboembolic Disease in Pulmonary Hypertension in Sickle Cell Disease

Mehdi Nouraie et al. Ann Am Thorac Soc. 2020 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Mean (SD) tricuspid regurgitation velocity by history of pulmonary embolism (PE) in the Walk-PHaSST (Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy) and University of Illinois at Chicago cohorts. In each cohort, P values were calculated from a multivariate regression analysis adjusted for age, sex, severe genotype, reticulocyte count, creatinine, and LV lateral E/A (Walk-PHaSST). TRV = tricuspid regurgitation velocity; UIC = University of Illinois at Chicago.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017;127:750–760. - PMC - PubMed
    1. Gladwin MT. Cardiovascular complications in patients with sickle cell disease. Hematology (Am Soc Hematol Educ Program) 2017;2017:423–430. - PMC - PubMed
    1. Anthi A, Machado RF, Jison ML, Taveira-Dasilva AM, Rubin LJ, Hunter L, et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med. 2007;175:1272–1279. - PMC - PubMed
    1. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(suppl)(25):D34–D41. - PubMed
    1. Noubiap JJ, Temgoua MN, Tankeu R, Tochie JN, Wonkam A, Bigna JJ. Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis. Thromb J. 2018;16:27. - PMC - PubMed